94th China International Pharmaceutical Ingredients, Intermediates, Packaging and Equipment Exhibition
2026-05-18
The annual flagship pharmaceutical and healthcare event will be held at the National Exhibition Center (Shanghai) from 13 to 15 May 2026. The 94th China International Pharmaceutical Ingredients, Intermediates, Packaging and Equipment Exhibition (API China) will be held simultaneously with the 92nd China Pharmaceutical Exhibition (PHARMCHINA) and the China International Health and Nutrition Exhibition (NHNE2026). The event, with the theme "Innovation as the driving force - connecting the future", will create a panoramic industry platform covering an area of more than 70,000 square meters, which will bring together more than 1,200 leading industry companies and over 30,000 professional decision makers.
94th China International Exhibition of Pharmaceutical Ingredients, Intermediates, Packaging Materials and Equipment.
（API China & PHARMPACK & SINOPHEX & PHARMEX）
Date: May 13–15, 2026.
Venue: National Exhibition Center (Shanghai).
Organizer: Guoyao Lizhan Exhibition Company Limited.
Exhibition Overview and Positioning: A Key Node of the Chinese Pharmaceutical Industry
The current API China exhibition takes full advantage of the world-class biopharmaceutical industrial cluster in the Yangtze River Delta region, covering the entire value chain from research and development to clinical trials, production and market application. Its main value lies in consolidation: it will bring together key decision makers from 97% of the leading Chinese pharmaceutical companies (including representatives of departments responsible for R&D, manufacturing, purchasing and quality control). This will create an indispensable, high-performance ecosystem for analyzing trends, making purchasing decisions and building strategic collaborations.
Key exhibition areas and focus on innovation: addressing key industry challenges
The exhibition has significantly updated two key exhibition areas, focused on advanced areas of industry development:
Biopharmaceutical Supply Chain Area:Key links are concentrated here - cell culture media, bioreactors, disposable technologies, and conferences are held on innovations in the field of anticancer drugs and environmentally friendly bioproduction.
Pharmaceutical Research and Development (CXO) Supply Chain Area:its theme is “differentiation, internationalization, innovation and collaboration in the supply chain.” It provides comprehensive CRO/CDMO/CMO services along the entire chain, as well as organized events to establish interaction between industry and the financial sector - all this is designed to speed up the transfer of scientific achievements from laboratory to production.
Exhibition matrix for the entire industry chain: a library of universal solutions
The exhibition topics systematically cover all aspects of the industry：
Basic materials:APIs, intermediates, pharmaceutical excipients, natural extracts.
Main equipment and technologies:pharmaceutical equipment, bioreactors, automation systems, special CGT equipment, clean and environmentally friendly solutions.
Packing and delivery:all kinds of pharmaceutical packaging materials, smart packaging, cold chain logistics solutions.
Research and development and services:full range of CXO services, registration consultations, pharmacovigilance and third party testing.
Multi-dimensional increase in exhibition value: a comprehensive transition from business opportunities to strategies
Participation in this event will bring multi-level benefits to the enterprise：
Maximum business efficiency:over 30 targeted sourcing meetings, historical data shows that 75% of professional audiences have completed purchase orders on the spot.
Wide network of contacts:direct dialogue with leading industry decision makers and influential buyers from more than 50 countries.
Understanding trends and strategic calibration:By participating in dozens of high-profile conferences, such as the China Pharmaceutical Technology Conference and the Overseas Supply Chain Conference, you can keep up with developments in global policy, technology and markets.
Transformation of innovative achievements:An exclusive platform for connecting industry and finance that brings together key capital and industrial resources for innovative technologies.
Joint intellectual forum: searching for ways to develop the industry
A series of high-level forums will focus on four key areas: “policy, technology, market and quality.” The forum will discuss current topics - pharmaceutical industry technologies, green sustainable development, innovations in the field of traditional Chinese medicine, pharmaceuticals for pets and quality management in enterprises. The purpose of the event is to bring together industry wisdom and find solutions to common development problems.
Continuation: going beyond the exhibition, jointly building a community for the future of the industry
The 94th API China 2026 is not just a three-day industry event, but a symbol of value resonance and ecosystem building together. At a time of accelerating restructuring of the global pharmaceutical supply chain and increasingly intense competition for innovation, the exhibition provides key infrastructure for bridging the information gap, reducing collaboration costs and accelerating the innovation cycle.
Here, enterprises are looking not only for suppliers or customers, but also for strategic partners who can withstand the uncertainty of the future; They receive not only orders, but also key insights into technology pathways, compliance strategies and market opportunities. We warmly invite innovators, decision-makers and builders of the global pharmaceutical and healthcare industry to come to Shanghai - here we can connect with the industry's most dynamic representatives, jointly define the rules of innovation and market conditions for the next decade, and together accelerate the movement of the entire industry towards a better, more efficient and sustainable future.
